Stella Diagnostics, Inc. (SLDX)
OTCMKTS · Delayed Price · Currency is USD
0.0140
0.00 (0.00%)
At close: Apr 30, 2026
Stella Diagnostics Market Cap
Stella Diagnostics has a market cap or net worth of $4.22 million as of May 8, 2026. Its market cap has decreased by -94.52% in one year.
Market Cap
4.22M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since July 7, 2008, Stella Diagnostics's market cap has increased from 15.00 to 4.22M, an increase of 28,140,406.67%. That is a compound annual growth rate of 102.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 4.22M | -75.56% |
| Dec 23, 2024 | 17.27M | 29.13% |
| Dec 29, 2023 | 13.37M | -44.17% |
| Dec 20, 2022 | 23.95M | -38.61% |
| Dec 30, 2021 | 39.02M | -11.01% |
| Dec 29, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioqual | 33.55M |
| Aspira Women's Health | 16.53M |
| Longduoduo Company | 15.31M |
| Psychemedics | 12.54M |
| iMD Companies | 5.84M |
| Centogene | 3.58M |
| Hypha Labs | 3.20M |
| InVitro International | 1.97M |